Φορτώνει......
Predictors of duration of abiraterone acetate in men with castration resistant prostate cancer
BACKGROUND: Androgen receptor signaling remains important in castration resistant prostate cancer (CRPC) as demonstrated by the efficacy of abiraterone acetate (henceforth abiraterone) in phase III trials. Given that heterogeneous patient responses are observed, we sought to determine clinical facto...
Αποθηκεύτηκε σε:
| Τόπος έκδοσης: | Prostate Cancer Prostatic Dis |
|---|---|
| Κύριοι συγγραφείς: | , , , , , |
| Μορφή: | Artigo |
| Γλώσσα: | Inglês |
| Έκδοση: |
2016
|
| Θέματα: | |
| Διαθέσιμο Online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6034654/ https://ncbi.nlm.nih.gov/pubmed/27502737 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/pcan.2016.31 |
| Ετικέτες: |
Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!
|